Literatur
- 1
Andersson K E, Chapple C R.
Oxybutynin and the overactive bladder.
World J Urol.
2001;
19
319-323
- 2 Bach D. Kathetermaterialien, Katheteraufbau und Kathetertypen. Jungjohann, Neckarsulm
In: Bach, D.; Brühl, P. (Hrsg): Harnwegsinfektionen 1995: 8-15
- 3
Carr L K, Walsh P J, Abraham V E, Webster G D.
Favorable outcome of pubovaginal slings for geriatric women with stress incontinence.
J Urol.
1997;
157
125-128
- 4 Engelmann H, Sundberg J. Harninkontinenz. De Gruyter, Berlin In: Fischer W, Köbel
H (Hrsg): Urogynäkologie in Praxis und Klinik 1995
- 5
Fall M, Lindstrom S.
Functional electrical stimulation: physiological basis and clinical principles.
Int Urogynecol J.
1994;
5
296-304
- 6 Fantl J A, Newman D K, Colling J. et al .Urinary Incontinence in Adults: Acute and
Chronic Management. Public Health Service, Agency for Health Care Policy and Research
Clinical Practice Guideline, No. 2. Rockville: Department of Health and Human Services
1996
- 7
Fusgen I.
Harninkontinenz im Alter.
Urologe A.
1991;
30
235-238
- 8
Fusgen I, Hauri D.
Trospium chloride: an effective option for medical treatment of bladder overactivity.
Int J Clin Pharmacol Ther.
2000;
38
223-234
- 9
Hay-Smith E J, Bo Berghmans L C, Hendriks H J. et al .
Pelvic floor muscle training for urinary incontinence in women.
Cochrane Database Syst Rev.
2001;
CD001407
- 10
Hay-Smith J, Herbison P, Ellis G, Moore K.
Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.
Cochrane Database Syst Rev.
2002;
3
CD003781
- 11
Junemann K P, Hoang-Bohm J, Wipfler G. et al .
Aktueller Therapiestandard in der Behandlung der genuinen Streßinkontinenz der Frau
mittels Harnröhren-Mini-Devices.
Urologe A.
1997;
36
405-412
- 12 Kennedy A. Bladder re-education for the promotion of continence. London: Prentice
Hall In: Roe, B (ed): Clinical Nursing Practice: The Promotion and Management of
Continence 1992: 77-93
- 13
Lawrence M, Guay D R, Benson S R, Anderson M J.
Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population
analysis.
Pharmacotherapy.
2000;
20
470-475
- 14
Pannek J, Haupt G, Sommerfeld H J. et al .
Urodynamic and rectomanometric findings in urinary incontinence.
Scand J Urol Nephrol.
1996;
30
457-460
- 15
Schwenzer T.
Derzeitiger Stand der medikamentösen Beeinflussbarkeit des unteren Harntraktes.
Gynakologe.
1992;
25
247-257
- 16
Sogbein S K, Awad S A.
Behavioural treatment of urinary incontinence in geriatric patients.
Can Med Assoc J.
1982;
127
863-864
- 17
Thüroff J W, Casper F, Heidler H.
Pelvic floor stress response: effect on periurethral muscle contraction and pelvic
floor tone on substitute urethra.
Neurourol Urodyn.
1987;
6
153
- 18
Ulmsten U, Falconer C, Johnson P. et al .
A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of
stress urinary incontinence.
Int Urogynecol J Pelvic Floor Dysfunct.
1998;
9
210-213
- 19
van Kerrebroeck P HEV.
Long-term tolerability and effcacy of once-daily (OD) tolterodine in the treatment
of overactive bladder (OAB).
Int Urogynecol J.
2001;
12
(Suppl 3)
549
Dr. med. Claus Hader
Zentrum für Innere Medizin Kliniken St. Antonius
Hardtstraße 46
42107 Wuppertal
Phone: 0202/299 4910
Fax: 0202/299 4015
Email: claushader@hotmail.com
